Not applicableStudy completedNCT02130011What this trial is testingDose-Guided Radiotherapy in Oesophageal Cancer: Managing the Real DoseWho this might be right forAdenocarcinoma Maastricht Radiation Oncology 20
Testing effectiveness (Phase 2)Study completedNCT00045526What this trial is testingErlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach CancerWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionRecurrent Esophageal Cancer+3 more National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)WithdrawnNCT06967987What this trial is testingStudy Evaluating the Combination of Bemarituzumab + FLOT Chemotherapy in Perioperative Setting for Resectable Stage cT2-T4a or N+ Gastric and GEJ Adenocarcinoma Overexpressing FGFR2bWho this might be right forGastric and Gastro-oesophageal Junction (GEJ) AdenocarcinomasOverexpression FGFR2b Institut Cancerologie de l'Ouest
Testing effectiveness (Phase 2)Study completedNCT00005599What this trial is testingBryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach CancerWho this might be right forEsophageal CancerGastric Cancer Memorial Sloan Kettering Cancer Center
Not applicableWithdrawnNCT05001360What this trial is testingStudy of FMT Combined With Nivolumab in Gastric CancerWho this might be right forGastric AdenocarcinomaEsophagogastric Junction AdenocarcinomaEsophagus Adenocarcinoma Fujian Cancer Hospital
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableStudy completedNCT04316078What this trial is testingA Novel Patient Engagement Platform Among Patients With Gastrointestinal MalignanciesWho this might be right forColon CancerGastric CancerPancreas Cancer+4 more Sheba Medical Center 126
Early research (Phase 1)Active Not RecruitingNCT03170960What this trial is testingStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forUrothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more Exelixis 914
Testing effectiveness (Phase 2)Looking for participantsNCT05965479What this trial is testingDeveloping ctDNA Guided Adjuvant Therapy for Gastrooesophageal CancerWho this might be right forGastrooesophageal Cancer University of Southampton 25
Not applicableLooking for participantsNCT04850729What this trial is testingRelationship Between Perioperative Treatment Efficacy and The Tumor Microenvironment for Locally Advanced Resectable Gastric Cancer.Who this might be right forGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma Nanfang Hospital, Southern Medical University 169
Very early researchStudy completedNCT03395847What this trial is testingPembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal AdenocarcinomaWho this might be right forAdvanced Gastroesophageal Junction AdenocarcinomaClinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8+22 more M.D. Anderson Cancer Center 9
Very early researchStudy completedNCT00215514What this trial is testingAdjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forStomach CancerGastric CancerGastro-esophageal Junction Cancer Dana-Farber Cancer Institute 25
Testing effectiveness (Phase 2)UnknownNCT01359397What this trial is testingDocetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric CancerWho this might be right forMetastatic Gastric CancerAdenocarcinoma of the Gastro-oesophageal Junction The Netherlands Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT06047379What this trial is testingSafety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisWho this might be right forDiffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more Neonc Technologies, Inc. 134
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06374888What this trial is testingNilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain MetastasesWho this might be right forHer2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis Convalife (Shanghai) Co., Ltd. 28
Testing effectiveness (Phase 2)Study completedNCT03283761What this trial is testingFOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction AdenocarcinomaWho this might be right forGastro-Esophageal Junction AdenocarcinomaGastric Cancer Al B. Benson, III, MD 39
Early research (Phase 1)Ended earlyNCT03809624What this trial is testingStudy of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck CancerWho this might be right forMetastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more Inhibrx Biosciences, Inc 160
Early research (Phase 1)Study completedNCT01671774What this trial is testingSafety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric CancerWho this might be right forCLDN18.2-positive Gastric AdenocarcinomaCLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of Esophagus Astellas Pharma Global Development, Inc. 29
Not applicableStudy completedNCT02310230What this trial is testingAn Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI EndoscopyWho this might be right forBiliary Tract DiseasesStomach NeoplasmsCarcinoma, Pancreatic Ductal+1 more Donald Mathews 100
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30